Page last updated: 2024-11-01

nifedipine and Hamartoma Syndrome, Multiple

nifedipine has been researched along with Hamartoma Syndrome, Multiple in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Hamartoma Syndrome, Multiple: A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Facial trichilemmomas and papillomatous papules of the oral mucosa are the most characteristic lesions. Individuals with this syndrome have a high risk of BREAST CANCER; THYROID CANCER; and ENDOMETRIAL CANCER. This syndrome is associated with mutations in the gene for PTEN PHOSPHATASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boisnic, S1
Frances, C1

Reviews

1 review available for nifedipine and Hamartoma Syndrome, Multiple

ArticleYear
[Gingival hypertrophy].
    Annales de dermatologie et de venereologie, 1988, Volume: 115, Issue:3

    Topics: Ascorbic Acid Deficiency; Cyclosporins; Female; Gingival Hypertrophy; Gingival Neoplasms; Hamartoma

1988